Jump to content

Chaetomium perlucidum

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Chaetomium perlucidum
Scientific classification Edit this classification
Domain: Eukaryota
Kingdom: Fungi
Division: Ascomycota
Class: Sordariomycetes
Order: Sordariales
Family: Chaetomiaceae
Genus: Chaetomium
Species:
C. perlucidum
Binomial name
Chaetomium perlucidum
Sergeeva (1956)
Synonyms
  • Chaetomium perlucidum Sergeeva [1]
  • Chaetomium perlucidum Sergeeva 1956 [2]
  • Chatomium perlucidum [2]

Chaetomium perlucidum is a neurotropic[3] dematiaceous (melanated cell wall)[4] fungus that is naturally found in the soil,[5] including in agricultural soil,[6] and in the stems of dead plants.[7] The fungus can also be found on the feathers of birds, manure, seeds, and even paper.[3] It is able to thrive at temperatures of 35 and 42 °C (95 and 108 °F).[3]

The fungus is an invasive opportunist[3][4] to humans that can cause diseases such as onychomycosis (fungus on nails), otolaryngologic (head and neck) or respiratory inflammations (like sinusitis, pneumonia, and empyema), and brain necrosis.[3]

History

It was first formally recorded in 1956 in Ukraine by K. S. Sergeeva.[1][8]

Morphology

Chaetomium perlucidum is pigmented and dark in colour, appearing hairy and wooly, with a growth rate of 4-5 mm/day.[3]

Perithecia (fruiting body)

Chaetomium perlucidum's fruiting bodies become fully mature in 13-16 days.[3] The fruiting body's structural width is 90-200 μm, with an ostiolar pore (open pore) width of 30-50 μm.[3]

Setae (bristle / "hair" structures)

Setae width is 2-3 μm and can have lengths of up to 700 μm.[3] The setae are unbranched and appear to undulate.[3]

Mature ascospores

Fully mature ascospores are 12.5-14 μm x 6-7.5 μm in size.[3] They are smooth, oval-shaped, and brown in colour.[3]

Lipid / fatty acid composition

Chaetomium perlucidum is composed of saturated, monounsaturated, and polyunsaturated fatty acids.

C. perlucidum fatty acid content[9]
Fatty acid Amount (%)
Pentadecylic acid / pentadecanoic acid (15:0, CH3(CH2)13COOH) 0.42 ± 0.33
Palmitic acid / hexadecanoic acid (16:0, C16H32O2) 18.95 ± 0.92
Palmitoleic acid (16:1, C16H30O2) trace amounts
Stearic acid / octadecanoic acid (18:0, C18H36O2) 6.76 ± 0.45
Oleic acid (18:1, CH3(CH2)7CH=CH(CH2)7COOH) 7.38 ± 5.79
Linoleic acid (18:2, C18H32O2) 63.48 ± 3.71

Pathogenicity

The fungus can cause chronic fungal infections in humans.[3][10] An infection can spread throughout the body from a single point of infection into various other systems, e.g., the central nervous, cardiovascular, respiratory, and immune systems, with especially a low prognosis for cerebral infections.[3]

Mode of transmission and infection

Infections take hold in the brain and progress to spread throughout the body.[3] Pathways of entry into the host's body include via cutaneous lesions, oral intake, or intravenously.[3]

Susceptibility

There have been at least two reported cases of cerebral phaeohyphomycosis in humans with one case resulting in death, reported in 2003.[3] Both cases occurred in immunosuppressed individuals already suffering from complications of other unrelated diseases.[3] Recreational drug users, or patients who have undergone intravenous or transplant procedures at even hospitals are also susceptible to being infected by C. perlucidum.[3]

Treatment and prognosis

Most Chaetomium fungal diseases are without known cure[3] and in one case of death from 1996, antifungal therapy through administering Amphotericin B (AMB) proved ineffective.[11] AMB is a common and leading antibiotic treatment prescribed for fungal infections.[12] In one case, C. perlucidum infection in the brain caused death from hemorrhaging throughout the body (especially in the brain) and complications that arose from acute inflammation.[3] However, the physical removal of a C. perlucidum growth through a lobectomy (surgically removing the fungal growth from an area of affected organ/s) was successful in curing another patient from infection.[3]

Culturing techniques

Chaetomium perlucidum ascospores can be cultured and grown in the lab through incubation on potato flake agar at 25°C for 6-10 days.[3] Optimal growth temperature however is at 37°C.[3] Mature perithecia can be obtained if the fungus has access to a sterile plant source.[3]

Occurrence in farming soil

Chaetomium perlucidum was found more frequently in tilled than in untilled farmland.[13]

References

  1. ^ a b Chaetomium perlucidum Sergeeva. GBIF.
  2. ^ a b Chaetomium perlucidum Sergeeva 1956. Uniprot.
  3. ^ a b c d e f g h i j k l m n o p q r s t u v w x y Barron, M. A.; Sutton, D. A.; Veve, R.; Guarro, J.; Rinaldi, M.; Thompson, E.; Cagnoni, P. J.; Moultney, K.; Madinger, N. E. (2003). "Invasive Mycotic Infections Caused by Chaetomium perlucidum, a New Agent of Cerebral Phaeohyphomycosis". Journal of Clinical Microbiology. 41 (11): 5302–5307. doi:10.1128/JCM.41.11.5302-5307.2003. ISSN 0095-1137. PMC 262481. PMID 14605190.
  4. ^ a b Phaeohyphomycosis - Infectious Diseases. Merck Manuals Professional Edition.
  5. ^ Ahmed, S. A.; Khan, Z.; Wang, X.; Moussa, T. A. A.; Al-Zahrani, H. S.; Almaghrabi, O. A.; Sutton, D. A.; Ahmad, S.; Groenewald, J. Z.; Alastruey-Izquierdo, A.; van Diepeningen, A. (2016). "Chaetomium-like fungi causing opportunistic infections in humans: a possible role for extremotolerance". Fungal Diversity. 76: 11–26. doi:10.1007/s13225-015-0338-5. ISSN 1878-9129.
  6. ^ Aggarwal, R.; Sharma, V.; Kharbikar, L. L. (2008). "Molecular characterization of Chaetomium species using URP-PCR". Genetics and Molecular Biology. 31 (4): 943–946. doi:10.1590/s1415-47572008005000014. ISSN 1415-4757.
  7. ^ Index Fungorum - Names Record. Index Fungorum.
  8. ^ Chaetomium perlucidum. Mycobank.
  9. ^ Stahl, P. D.; Klug, M. J. (1996). "Characterization and Differentiation of Filamentous Fungi Based on Fatty Acid Composition". Applied and Environmental Microbiology. 62 (11): 4136–46. Bibcode:1996ApEnM..62.4136S. doi:10.1128/aem.62.11.4136-4146.1996. PMC 1388980. PMID 16535442.
  10. ^ Chhonkar, A.; Kataria, D.; Tambe, S.; Nayak, C. S. (2016). "Three rare cases of cutaneous phaeohyphomycosis". Indian Journal of Plastic Surgery. 49 (2): 271–274. doi:10.4103/0970-0358.191321. ISSN 0970-0358. PMC 5053006. PMID 27833296.
  11. ^ Yeghen, T.; Fenelon, L.; Campbell, C. K.; Warnock, D. W.; Hoffbrand, A. V.; Prentice, H. G.; Kibbler, C. C. (1996). "Chaetomium pneumonia in patient with acute myeloid leukaemia". Journal of Clinical Pathology. 49 (2): 184–186. doi:10.1136/jcp.49.2.184. ISSN 0021-9746. PMC 500362. PMID 8655695.
  12. ^ Torrado, J. J.; Espada, R.; Ballesteros, M. P.; Torrado-Santiago, S. (2008). "Amphotericin B Formulations and Drug Targeting". Journal of Pharmaceutical Sciences. 97 (7): 2405–2425. doi:10.1002/jps.21179. ISSN 0022-3549. PMID 17893903.
  13. ^ Sharma-Poudyal, D.; Schlatter, D.; Yin, C.; Hulbert, S.; Paulitz, T. (2017). "Long-term no-till: A major driver of fungal communities in dryland wheat cropping systems". PLOS ONE. 12 (9): e0184611. Bibcode:2017PLoSO..1284611S. doi:10.1371/journal.pone.0184611. ISSN 1932-6203. PMC 5595340. PMID 28898288.